Breakthrough trial tests common arthritis drug against Virus-Linked joint damage
NCT ID NCT04483466
Summary
This study tests whether methotrexate, a medication used for rheumatoid arthritis, can reduce chronic joint pain and swelling in people who developed arthritis after chikungunya virus infection. 150 adults in Colombia with arthritis lasting over 3 months will receive either methotrexate or placebo pills for 6 months, with researchers measuring changes in joint symptoms. The trial aims to provide the first solid evidence about whether this widely available drug can effectively control this persistent viral arthritis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVESTIGATE THE EFFECT(S) OF METHOTREXATE TREATMENT ON ARTHRITIS DISEASE SEVERITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica de la Costa
Barranquilla, Colombia
Conditions
Explore the condition pages connected to this study.